ACRS
Aclaris Therapeutics, Inc.Company with tickers: ACRS
CIK
1557746
CUSIP
00461U105
Shares Outstanding
139,663,680
13F Activity (30d)
84 filings
81 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2020-01-08 | 2020-01-07 | |
| 8-K | 2020-01-13 | — | |
| 8-K | 2020-02-25 | — | |
| 10-K | 2020-02-25 | 2019-12-31 | |
| 8-K | 2020-03-13 | — | |
| 8-K | 2020-03-31 | 2020-03-30 | |
| DEF 14A | 2020-04-23 | 2020-06-04 | |
| 8-K | 2020-05-07 | — | |
| 10-Q | 2020-05-07 | 2020-03-31 | |
| 8-K | 2020-05-15 | — | |
| 8-K | 2020-05-27 | — | |
| 8-K | 2020-06-04 | — | |
| 8-K | 2020-06-17 | — | |
| 8-K | 2020-06-24 | 2020-06-23 | |
| 8-K | 2020-08-07 | — | |
| 10-Q | 2020-08-07 | 2020-06-30 | |
| 8-K | 2020-08-13 | — | |
| 8-K | 2020-08-14 | 2020-08-13 | |
| 8-K | 2020-09-15 | — | |
| 8-K | 2020-11-04 | — | |
| 10-Q | 2020-11-04 | 2020-09-30 | |
| 8-K | 2020-12-15 | — | |
| 8-K | 2021-01-19 | — | |
| 8-K | 2021-01-22 | 2021-01-19 | |
| 8-K | 2021-02-25 | — | |
| 10-K | 2021-02-25 | 2020-12-31 | |
| DEF 14A | 2021-04-22 | 2021-06-03 | |
| 10-Q | 2021-05-07 | 2021-03-31 | |
| 8-K | 2021-05-07 | — | |
| 8-K | 2021-05-20 | — | |
| 8-K | 2021-06-03 | — | |
| 8-K | 2021-06-08 | — | |
| 8-K | 2021-06-11 | 2021-06-08 | |
| 8-K | 2021-07-26 | 2021-07-23 | |
| 8-K | 2021-08-05 | — | |
| 10-Q | 2021-08-05 | 2021-06-30 | |
| 8-K | 2021-08-27 | — | |
| 10-Q | 2021-11-02 | 2021-09-30 | |
| 8-K | 2021-11-02 | 2021-11-01 | |
| 8-K | 2021-12-07 | — | |
| 8-K | 2022-01-14 | 2022-01-12 | |
| 8-K | 2022-02-24 | — | |
| 10-K | 2022-02-24 | 2021-12-31 | |
| 8-K | 2022-04-14 | 2022-04-13 | |
| DEF 14A | 2022-04-21 | 2022-06-02 | |
| 10-Q | 2022-05-10 | 2022-03-31 | |
| 8-K | 2022-05-10 | — | |
| 8-K | 2022-06-03 | 2022-06-02 | |
| 8-K | 2022-08-01 | — | |
| 10-Q | 2022-08-03 | 2022-06-30 |
Showing 1–50 of 117 filings